UCB
| Use attributes for filter ! | |
| Stock price | UCB |
|---|---|
| Disclaimer | |
| Headquarters | Brussels |
| Belgium | |
| Ceo | Jean-Christophe Tellier |
| Founders | Emmanuel Janssen |
| Founded | January 18 |
| 1928 | |
| Revenue | 4. 632 billion EUR (2018) |
| Subsidiaries | UCB, Inc. |
| Celltech | |
| Element Genomics, Inc. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2324479 |
About UCB
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4. 178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases.
